• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌细胞淋巴扩散的淋巴动力学因素]

[Lymphodynamic factors governing lymphatic spread of carcinoma cells].

作者信息

Ohhashi T

机构信息

First Department of Physiology, Shinshu University School of Medicine, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 2001 Jun;102(6):435-9.

PMID:11436503
Abstract

Carcinoma frequently spreads and grows through the lymphatic system, whereas malignant tumors of mesenchymal origin more frequently spread via the hematogenous route. This paper reviews cancer spread with special reference to tumor microcirculation, vascular endothelial growth factor receptor (VEGFR)-3-mediated lymphangiogenesis, regeneration of collecting lymph vessels, and the role of nitric oxide in lymphatic metastasis. Oxygen and pH are key microenvironmental factors in the development and growth of tumors and their response to treatment. Thus the physiological and pathophysiological roles of hypoxia and acidic pH in the tumor microenvironment in lymphatic metastasis are demonstrated. Lymph angiogenesis in tumor tissues and regeneration of collecting lymph vessels with special reference to VEGFR-3 and its agonists VEGF-C/VEGF-D are discussed. The occurrence and biological significance of intratumoral lymph angiogenesis in breast cancer have been established. VEGF-C as a molecular link between tumor lymph angiogenesis and metastasis is identified. Finally, the role of nitric oxide (NO) in tumor microcirculation and lymphatic metastasis of carcinoma cells is evaluated.

摘要

癌常常通过淋巴系统扩散和生长,而间充质起源的恶性肿瘤则更常通过血行途径扩散。本文回顾了癌症的扩散,特别提及肿瘤微循环、血管内皮生长因子受体(VEGFR)-3介导的淋巴管生成、集合淋巴管的再生以及一氧化氮在淋巴转移中的作用。氧气和pH值是肿瘤发生发展及其对治疗反应的关键微环境因素。因此,本文证明了缺氧和酸性pH值在肿瘤微环境中对淋巴转移的生理和病理生理作用。本文讨论了肿瘤组织中的淋巴管生成以及集合淋巴管的再生,特别提及VEGFR-3及其激动剂VEGF-C/VEGF-D。乳腺癌肿瘤内淋巴管生成的发生及其生物学意义已得到证实。VEGF-C被确定为肿瘤淋巴管生成与转移之间的分子联系。最后,评估了一氧化氮(NO)在肿瘤微循环和癌细胞淋巴转移中的作用。

相似文献

1
[Lymphodynamic factors governing lymphatic spread of carcinoma cells].[癌细胞淋巴扩散的淋巴动力学因素]
Nihon Geka Gakkai Zasshi. 2001 Jun;102(6):435-9.
2
Molecular control of lymphatic metastasis.淋巴转移的分子调控
Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020.
3
Lymphatic versus blood vascular endothelial growth factors and receptors in humans.人类体内的淋巴管与血管内皮生长因子及受体
Microsc Res Tech. 2001 Oct 15;55(2):108-21. doi: 10.1002/jemt.1162.
4
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.选择性剪接的flt-4的短形式而非其配体血管内皮生长因子C与人类乳腺癌的淋巴结转移有关。
Clin Cancer Res. 2000 Nov;6(11):4278-86.
5
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.血管内皮生长因子C促进肿瘤淋巴管生成和肿瘤在淋巴管内生长。
Cancer Res. 2001 Mar 1;61(5):1786-90.
6
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.健康和关节炎滑膜中血管和淋巴管内的血管内皮生长因子C和D及其VEGFR-2和3受体
J Rheumatol. 2002 Jan;29(1):39-45.
7
Lymphatic endothelium: a new frontier of metastasis research.淋巴管内皮:转移研究的新前沿。
Nat Cell Biol. 2002 Jan;4(1):E2-5. doi: 10.1038/ncb0102-e2.
8
Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.血管内皮生长因子(VEGF)-C和VEGF-D在免疫健全大鼠肿瘤中的体内和体外差异表达及其与淋巴转移的关系
Cancer Res. 2003 Feb 1;63(3):713-22.
9
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.血管内皮生长因子-C诱导肿瘤淋巴管生成促进乳腺癌转移。
Nat Med. 2001 Feb;7(2):192-8. doi: 10.1038/84643.
10
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.血管内皮生长因子受体在血管生成和淋巴管生成调控中的作用
Oncogene. 2000 Nov 20;19(49):5598-605. doi: 10.1038/sj.onc.1203855.